These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1447 related items for PubMed ID: 11128672

  • 21. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS, Cho ML, Joo YS, Kim WU, Hong YS, Min JK, Lee SH, Park SH, Cho CS, Kim HY.
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [Abstract] [Full Text] [Related]

  • 22. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J, Swadzba J, Motyl A, Iwaniec T.
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [Abstract] [Full Text] [Related]

  • 23. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
    Hanly JG, Smith SA.
    J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
    [Abstract] [Full Text] [Related]

  • 24. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M, Duzgun N, Tunc SE, Tutkak H.
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [Abstract] [Full Text] [Related]

  • 25. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 26. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A.
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [Abstract] [Full Text] [Related]

  • 27. Antiphospholipid antibodies in arterial thrombosis.
    Koike T.
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [Abstract] [Full Text] [Related]

  • 28. Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Obermoser G, Bitterlich W, Kunz F, Sepp NT.
    Int Arch Allergy Immunol; 2004 Oct; 135(2):148-53. PubMed ID: 15345914
    [Abstract] [Full Text] [Related]

  • 29. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR, Dier KJ, Lopez D, Merrill JT, Fink CA.
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [Abstract] [Full Text] [Related]

  • 30. Association of antimitochondrial antibodies type 5 and anti-beta 2 glycoprotein I antibodies in the antiphospholipid syndrome.
    Laperche S, Abuaf N, Meyer O, Carsique R, Deschamps A, Rajoely B, Johanet C, Homberg JC.
    J Rheumatol; 1994 Sep; 21(9):1678-83. PubMed ID: 7799349
    [Abstract] [Full Text] [Related]

  • 31. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

  • 32. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 33. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
    Nojima J, Masuda Y, Iwatani Y, Kuratsune H, Watanabe Y, Suehisa E, Takano T, Hidaka Y, Kanakura Y.
    Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
    [Abstract] [Full Text] [Related]

  • 34. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS, Kim KE, Kim JM, Han JY, Chung WT, Kim KH.
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [Abstract] [Full Text] [Related]

  • 35. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D, Alessio MG, Tampoia M, Da Re A, Stella S, Da Re M, Tozzoli R, Bizzaro N.
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [Abstract] [Full Text] [Related]

  • 36. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D, Mestanza M, Cabiedes J, Cabral AR.
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [Abstract] [Full Text] [Related]

  • 37. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
    Aleksandrova EN, Novikov AA, Reshetniak TM, Kliukvina HG, Reshetniak DV, Nasonov EL.
    Klin Med (Mosk); 2003 Aug; 81(9):25-31. PubMed ID: 14598587
    [Abstract] [Full Text] [Related]

  • 38. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Aug; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 39. [Antibodies to beta2-glycoprotein-1 in patients with systemic lupus erythematosus].
    Borodin AG, Baranov NG, Nasonov EL.
    Klin Med (Mosk); 2001 Aug; 79(2):49-51. PubMed ID: 11419087
    [Abstract] [Full Text] [Related]

  • 40. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V, Verasertniyom O, Vanichapuntu M, Totemchokchyakarn K, Nantiruj K, Pisitkul P, Angchaisuksiri P, Archararit N, Rachakom B, Ayurachai K, Janwityanujit S.
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 73.